Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

March
16
2021

Colorado State University, Flint Animal Cancer Center Applies Sensus Healthcare’s SRT Non-Surgical Treatment to Animal Care

Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options in veterinary settings BOCA RATON, Fla, March 16, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS),…

March
08
2021

Sensus Healthcare to Participate in Three Investment Conferences During the Month of March

BOCA RATON, Fla, March 08, 2021 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that Joe Sardano,…

March
02
2021

Skin Cancer Treatment Side Effects

Skin Cancer Treatment Side Effects Receiving a skin cancer diagnosis, no matter the stage or type, can be intimidating to hear. The first thing you might do after receiving a diagnosis is research treatment options…

February
25
2021

Sensus Healthcare Reports Fourth Quarter and Full Year 2020 Financial Results

Achieves fourth quarter net income of $1.0 million on revenues of $5.1 million Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 25, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy